Tammo Omer, Söylemez Esra, Bayhan Hüseyin
Department of Gynecology and Obstetrics, Harran University, Sanlıurfa, Turkey.
Department of Obstetrics and Gynecology, Mardin, Turkey.
BMC Surg. 2025 Jul 16;25(1):297. doi: 10.1186/s12893-025-03039-9.
Obesity is a significant public health problem with increasing prevalence worldwide, and polycystic ovary syndrome (PCOS) is a common comorbidity in obese women. PCOS is characterized by hormonal imbalances, menstrual irregularities, infertility, and metabolic disorders. Weight management is critical in obese women with PCOS to improve both reproductive health and achieve metabolic and hormonal balance. To this end, surgical treatments have come to the forefront, and procedures such as laparoscopic sleeve gastrectomy (LSG) and endoscopic intragastric balloon (EIB) placement are being used increasingly.
This is a retrospective study conducted at [Blinded for review] between January 2022 and October 2024. It compares the effects of laparoscopic sleeve gastrectomy and endoscopic intragastric balloon placement in female patients aged 18-40 who were diagnosed with PCOS and obesity. In the study, anthropometric measurements, hormonal parameters, and menstrual cycles were evaluated before treatment and 6 months after treatment and analyzed between the two groups. There was no difference in age between patients who underwent laparoscopic sleeve gastrectomy and endoscopic intragastric balloon placement (p = 0.424). The preoperative BMI and the difference between preoperative and postoperative BMI were higher in the LSG group (p < 0.001), but the postoperative BMI values were similar between the two groups (p = 0.583). The waist/hip ratio was higher in the LSG group (p < 0.001, p = 0.010, p < 0.001). While both surgeries showed a reduction in free androgen index and AMH, this reduction was not statistically significant (p > 0.05), both surgeries increased SHBG (p > 0.05). The decrease in AMH was greater in the LSG group (p = 0.020). Total testosterone decreased in the sleeve gastrectomy group (p < 0.001) and the menstrual cycle improved (p = 0.035).
In summary, both laparoscopic sleeve gastrectomy and endoscopic intragastric balloon placement led to positive changes in hormone profiles and menstrual cycle characteristics. However, LSG was found to be more effective on these parameters.
肥胖是一个重大的公共卫生问题,在全球范围内患病率不断上升,多囊卵巢综合征(PCOS)是肥胖女性中常见的合并症。PCOS的特征是激素失衡、月经不规律、不孕和代谢紊乱。体重管理对于肥胖的PCOS女性至关重要,有助于改善生殖健康并实现代谢和激素平衡。为此,手术治疗已成为前沿方法,诸如腹腔镜袖状胃切除术(LSG)和内镜胃内球囊(EIB)置入等手术越来越多地被采用。
这是一项于2022年1月至2024年10月在[审核时 blinded]进行的回顾性研究。它比较了腹腔镜袖状胃切除术和内镜胃内球囊置入对18至40岁被诊断为PCOS和肥胖的女性患者的影响。在该研究中,对治疗前和治疗后6个月的人体测量指标、激素参数和月经周期进行了评估,并在两组之间进行了分析。接受腹腔镜袖状胃切除术和内镜胃内球囊置入的患者年龄无差异(p = 0.424)。LSG组术前BMI以及术前与术后BMI的差值更高(p < 0.001),但两组术后BMI值相似(p = 0.583)。LSG组腰臀比更高(p < 0.001,p = 0.010,p < 0.001)。虽然两种手术均显示游离雄激素指数和抗苗勒管激素(AMH)降低,但这种降低无统计学意义(p > 0.05),两种手术均使性激素结合球蛋白(SHBG)升高(p > 0.05)。LSG组AMH的降低幅度更大(p = 0.020)。袖状胃切除术组总睾酮降低(p < 0.001),月经周期改善(p = 0.035)。
总之,腹腔镜袖状胃切除术和内镜胃内球囊置入均导致激素谱和月经周期特征出现积极变化。然而,发现LSG在这些参数上更有效。